Genetic alterations of multiple tumor suppressors and oncogenes in the carcinogenesis and progression of lung cancer

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Oncogene

• Publication date

  2002-10-21

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/sj.onc.1205802PMID 12379883
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• High K-ras mutation rates in goblet-cell-type adenocarcinomas of the lungs

  2005cited by this paper
• E2F integrates cell cycle progression with DNA repair, replication, and G(2)/M checkpoints.

  2002cited by this paper
• Regulation of p53 activity by its interaction with homeodomain-interacting protein kinase-2

  2002cited by this paper
• Homeodomain-interacting protein kinase-2 phosphorylates p53 at Ser 46 and mediates apoptosis

  2002cited by this paper
• Identification of frequent G(2) checkpoint impairment and a homozygous deletion of 14-3-3epsilon at 17p13.3 in small cell lung cancers.

  2002cited by this paper
• Frequent and histological type-specific inactivation of 14-3-3σ in human lung cancers

  2002cited by this paper
• Tumor suppressor PTEN: modulator of cell signaling, growth, migration and apoptosis.

  2001cited by this paper
• Inadequate lung development and bronchial hyperplasia in mice with a targeted deletion in the Dutt1/Robo1 gene

  2001cited by this paper
• Inhibition of lung cancer cell growth and induction of apoptosis after reexpression of 3p21.3 candidate tumor suppressor gene SEMA3B

  2001cited by this paper
• Expression analysis using DNA microarrays demonstrates that E2F-1 up-regulates expression of DNA replication genes including replication protein A2

  2001cited by this paper
• Analysis of the transcriptional program induced by Raf in epithelial cells

  2001cited by this paper
• HER-2/neu induces p53 ubiquitination via Akt-mediated MDM2 phosphorylation

  2001cited by this paper
• Fibronectin, integrins, and growth control

  2001cited by this paper
• A CDK-independent function of mammalian Cks1: targeting of SCF(Skp2) to the CDK inhibitor p27Kip1.

  2001cited by this paper
• E2Fs regulate the expression of genes involved in differentiation, development, proliferation, and apoptosis.

  2001cited by this paper
• The expression of vascular endothelial growth factor C and its receptors in non-small cell lung cancer

  2001cited by this paper
• Akt/protein kinase B is constitutively active in non-small cell lung cancer cells and promotes cellular survival and resistance to chemotherapy and radiation.

  2001cited by this paper
• Mutability of p53 hotspot codons to benzo(a)pyrene diol epoxide (BPDE) and the frequency of p53 mutations in nontumorous human lung.

  2001cited by this paper
• Salvage chemotherapy with high-dose leucovorin (LV) and 48-hour continuous infusion (CI) of 5-fluorouracil (5-FU) in combination with conventional doses of cyclophosphamide (CPM) in patients with metastatic breast cancer (MBC) pretreated with anthracycline and taxanes

  2001cited by this paper
• Fecal shedding of hepatitis A virus in Indian patients with hepatitis A and in experimentally infected Rhesus monkey.

  2001cited by this paper
• Diversity of gene expression in adenocarcinoma of the lung

  2001cited by this paper
• Patterns of p53 G-->T transversions in lung cancers reflect the primary mutagenic signature of DNA-damage by tobacco smoke.

  2001cited by this paper
• The cell-cycle regulatory protein Cks1 is required for SCFSkp2-mediated ubiquitinylation of p27

  2001cited by this paper
• TSLC1 is a tumor-suppressor gene in human non-small-cell lung cancer

  2001cited by this paper
• Lung cancer: principles and practice

  2001cited by this paper
• Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses

  2001cited by this paper
• PUMA induces the rapid apoptosis of colorectal cancer cells.

  2001cited by this paper
• Anticancer therapy targeting the erbB family of receptor tyrosine kinases.

  2001cited by this paper
• Inhibition of anchorage-independent growth and lung metastasis of A549 lung carcinoma cells by IkappaBbeta.

  2001cited by this paper
• Repression of p15INK4b expression by Myc through association with Miz-1

  2001cited by this paper
• Significant correlation between interleukin 10 expression and vascularization through angiopoietin/TIE2 networks in non-small cell lung cancer.

  2001cited by this paper
• Epigenetic inactivation of RASSF1A in lung and breast cancers and malignant phenotype suppression.

  2001cited by this paper
• APAF-1 is a transcriptional target of p53 in DNA damage-induced apoptosis.

  2001cited by this paper
• Heterogeneous transforming growth factor (TGF)-beta unresponsiveness and loss of TGF-beta receptor type II expression caused by histone deacetylation in lung cancer cell lines.

  2001cited by this paper
• Distinct pattern of E2F1 expression in human lung tumours: E2F1 is upregulated in small cell lung carcinoma

  2001cited by this paper
• Relation of hypoxia inducible factor 1α and 2α in operable non-small cell lung cancer to angiogenic/molecular profile of tumours and survival

  2001cited by this paper
• Direct regulation of the centrosome duplication cycle by the p53-p21Waf1/Cip1 pathway

  2001cited by this paper
• Methylation associated inactivation of RASSF1A from region 3p21.3 in lung, breast and ovarian tumours

  2001cited by this paper
• TGFβ influences Myc, Miz-1 and Smad to control the CDK inhibitor p15INK4b

  2001cited by this paper
• Anoikis mechanisms.

  2001cited by this paper
• The bmi-1 oncoprotein is differentially expressed in non-small cell lung cancer and correlates with INK4A-ARF locus expression

  2001cited by this paper
• Role for E2F in Control of Both DNA Replication and Mitotic Functions as Revealed from DNA Microarray Analysis

  2001cited by this paper
• The tumor spectrum in FHIT-deficient mice

  2001cited by this paper
• Inhibition of anchorage-independent growth and lung metastasis of A549 lung carcinoma cells by IκBβ

  2001cited by this paper
• p53R2-dependent pathway for DNA synthesis in a p53-regulated cell cycle checkpoint.

  2001cited by this paper
• Tie receptors: new modulators of angiogenic and lymphangiogenic responses

  2001cited by this paper
• Persistent increase in chromosome instability in lung cancer: possible indirect involvement of p53 inactivation.

  2001influential reference
• The molecular effects of oncogenesis on cell-extracellular matrix adhesion (review).

  2001cited by this paper
• Protective function of p27(KIP1) against apoptosis in small cell lung cancer cells in unfavorable microenvironments.

  2001cited by this paper
• p53AIP1, a potential mediator of p53-dependent apoptosis, and its regulation by Ser-46-phosphorylated p53.

  2000cited by this paper
• Expression analysis with oligonucleotide microarrays reveals that MYC regulates genes involved in growth, cell cycle, signaling, and adhesion.

  2000cited by this paper
• TGFbeta signaling in growth control, cancer, and heritable disorders.

  2000cited by this paper
• TGF-beta signaling by Smad proteins.

  2000cited by this paper
• Noxa, a BH3-only member of the Bcl-2 family and candidate mediator of p53-induced apoptosis.

  2000cited by this paper
• Prognostic significance of p53 alterations in patients with non-small cell lung cancer: a meta-analysis.

  2000cited by this paper
• Fruitfly centre spreads its wings

  2000cited by this paper
• Inactivation of 14-3-3ς Influences Telomere Behavior and Ionizing Radiation-Induced Chromosomal Instability

  2000cited by this paper
• Vascular endothelial growth factor receptors in the regulation of angiogenesis and lymphangiogenesis

  2000influential reference
• Evolutionary genetics: fruitfly centre spreads its wings.

  2000cited by this paper
• Surfing the p53 network

  2000cited by this paper
• The 630-kb lung cancer homozygous deletion region on human chromosome 3p21.3: identification and evaluation of the resident candidate tumor suppressor genes. The International Lung Cancer Chromosome 3p21.3 Tumor Suppressor Gene Consortium.

  2000cited by this paper
• Mice without telomerase: what can they teach us about human cancer?

  2000cited by this paper
• Infrequent Mutation of the hBUB1 and hBUBR1 Genes in Human Lung Cancer

  2000cited by this paper
• Histological type-selective, tumor-predominant expression of a novel CHK1 isoform and infrequent in vivo somatic CHK2 mutation in small cell lung cancer.

  2000cited by this paper
• Detection of codon 12 K- ras mutations in non-neoplastic mucosa from bronchial carina in patients with lung adenocarcinomas

  2000cited by this paper
• Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3

  2000cited by this paper
• Loss of Fhit expression in non-small-cell lung cancer: correlation with molecular genetic abnormalities and clinicopathological features

  2000cited by this paper
• Vascular endothelial growth factor expression and neovascularisation in non-small cell lung cancer.

  2000cited by this paper
• MDM2 mRNA expression is a favorable prognostic factor in non‐small‐cell lung cancer

  2000cited by this paper
• c-Myc suppresses the tumorigenicity of lung cancer cells and down-regulates vascular endothelial growth factor expression.

  2000cited by this paper
• A dominant role for the c-Jun NH2-terminal kinase in oncogenic ras-induced morphologic transformation of human lung carcinoma cells.

  2000cited by this paper
• Cell signaling by receptor tyrosine kinases.

  2000cited by this paper
• Vascular endothelial growth factor, platelet-derived endothelial cell growth factor and angiogenesis in non-small-cell lung cancer

  2000cited by this paper
• Correlation of total VEGF mRNA and protein expression with histologic type, tumor angiogenesis, patient survival and timing of relapse in non‐small‐cell lung cancer

  2000cited by this paper
• Nucleolar Arf sequesters Mdm2 and activates p53

  1999cited by this paper
• The tumor-suppressor gene FHIT is involved in the regulation of apoptosis and in cell cycle control.

  1999cited by this paper
• Telomerase repressor sequences on chromosome 3 and induction of permanent growth arrest in human breast cancer cells.

  1999cited by this paper
• Inactivation of the INK4A/ARF locus frequently coexists with TP53 mutations in non-small cell lung cancer

  1999cited by this paper
• Expression of vascular endothelial growth factor mRNA in non-small-cell lung carcinomas

  1999cited by this paper
• Search for in vivo somatic mutations in the mitotic checkpoint gene, hMAD1, in human lung cancers

  1999cited by this paper
• Alterations of the PPP1R3 gene in human cancer.

  1999cited by this paper
• Association of p19ARF with Mdm2 inhibits ubiquitin ligase activity of Mdm2 for tumor suppressor p53

  1999influential reference
• Cyclins D1 and D2 mediate Myc‐induced proliferation via sequestration of p27Kip1 and p21Cip1

  1999cited by this paper
• Expression of vascular endothelial growth factor (VEGF) and its two receptors (VEGF‐R1‐Flt1 and VEGF‐R2‐Flk1/KDR) in non‐small cell lung carcinomas (NSCLCs): correlation with angiogenesis and survival

  1999cited by this paper
• Enhanced expression of Tie2, its ligand angiopoietin-1, vascular endothelial growth factor, and CD31 in human non-small cell lung carcinomas.

  1999cited by this paper
• Role of FHIT in human cancer.

  1999cited by this paper
• Mutations in human ARF exon 2 disrupt its nucleolar localization and impair its ability to block nuclear export of MDM2 and p53.

  1999cited by this paper
• Identification of frequent impairment of the mitotic checkpoint and molecular analysis of the mitotic checkpoint genes, hsMAD2 and p55CDC, in human lung cancers

  1999cited by this paper
• Direct activation of TERT transcription by c-MYC

  1999cited by this paper
• Mutation analysis of hBUB1 in aneuploid HNSCC and lung cancer cell lines.

  1999cited by this paper
• Alpha5beta1 integrin controls cyclin D1 expression by sustaining mitogen-activated protein kinase activity in growth factor-treated cells.

  1999cited by this paper
• RB-mediated suppression of spontaneous multiple neuroendocrine neoplasia and lung metastases in Rb+/- mice.

  1999cited by this paper
• Identification and classification of p53-regulated genes.

  1999cited by this paper
• Refined mapping of two regions of loss of heterozygosity on chromosome band 11q23 in lung cancer

  1999cited by this paper
• Role of FHIT in Human Cancer

  1999cited by this paper
• α5β1 Integrin Controls Cyclin D1 Expression by Sustaining Mitogen-activated Protein Kinase Activity in Growth Factor-treated Cells

  1999cited by this paper
• Myc activates telomerase.

  1998cited by this paper
• Localization of tumor suppressor activity important in nonsmall cell lung carcinoma on chromosome 11q.

  1998cited by this paper
• p27KIP1 in human lung cancers: differential changes in small cell and non-small cell carcinomas.

  1998cited by this paper
• p19ARF links the tumour suppressor p53 to Ras

  1998cited by this paper

• Frequent Loss of CACNA1C Is Associated With Poor Prognosis in Non‐Small Cell Lung Cancer

  2026cites this paper
• Oncogenic Function of miR-182-5p Versus Tumor-Suppressive Activities of miR-203, miR-150-5p, and miR-139-5p via Target Gene Regulation in Colon Cancer Metastasis

  2025cites this paper
• Identification and Biological Validation of MMP-12 Inhibitors Guided by Pharmacophore-Based Virtual Screening and Docking Studies

  2025cites this paper
• Deciphering molecular pathways in urological cancers: a gateway to precision therapeutics.

  2025cites this paper
• The mechanism underlying the oncogenic potential of AAA+ ATPase PSMC4 in cancer is revealed by mutations and copy number amplifications.

  2025cites this paper
• A comprehensive pan-cancer analysis of RNF187 in human tumors

  2025cites this paper
• A review on progress of thiazole derivatives as potential anti-inflammatory agents

  2024cites this paper
• PFKFB3-dependent redox homeostasis and DNA repair support cell survival under EGFR-TKIs in non-small cell lung carcinoma

  2024cites this paper
• An insight into the anticancer potentials of lignan arctiin: A comprehensive review of molecular mechanisms

  2024cites this paper
• Selected aspects of avascular tumor growth reproduced by a hybrid model of cell dynamics and chemical kinetics.

  2024cites this paper
• One-Week Kava Dietary Supplementation Increases Both Urinary N- and O-Glucuronides of NNAL, a Lung Carcinogen Major Metabolite, among Smokers.

  2024cites this paper
• Anti-tumor Activity of Schoenoplectus triqueter Extract by Suppressing the STAT3 Signaling Pathway in A549 Lung Adenocarcinoma Cells

  2024cites this paper
• The mathematical exploration for the mechanism of lung adenocarcinoma formation and progression

  2024cites this paper
• Precision Targeting of Non-Small Cell Lung Cancer: Identifying Optimal Drug Targets and FDA-Approved Combinations for Enhanced Therapeutic Efficacy

  2023cites this paper
• Epigenetic regulation in lung cancer

  2023cites this paper
• Pyrogallol promotes growth arrest by activating the p53‐mediated up‐regulation of p21 and p62/SQSTM1‐dependent degradation of β‐catenin in nonsmall cell lung cancer cells

  2023cites this paper
• Molecular characterization of early breast cancer onset to understand disease phenotypes in African patients

  2022cites this paper
• MPZL1 upregulation promotes tumor metastasis and correlates with unfavorable prognosis in non-small cell lung cancer.

  2022cites this paper
• Head and neck squamous cell carcinoma: a potential therapeutic target for the Wnt signaling pathway

  2022cites this paper
• The role of oncogenes and tumor suppressor genes in determining survival rates of lung cancer patients in the population of North Sumatra, Indonesia

  2022cites this paper
• The Effectiveness of Various Chemotherapeutic Agents in Cancer Treatment

  2022cites this paper
• Elevated FAM84B promotes cell proliferation via interacting with NPM1 in esophageal squamous cell carcinoma

  2022cites this paper
• Somatic copy number alterations modulate tumor suppressor and oncogene expression to drive early onset of breast cancer

  2022cites this paper
• Prognostic impact of primary cancer adjoining emphysematous bullae in non-small cell lung cancer patients treated with immune checkpoint inhibitors

  2021cites this paper
• A phenotype-structured model to reproduce the avascular growth of a tumor and its interaction with the surrounding environment.

  2021cites this paper
• Prediction of Genes Involved in Lung Cancer with a Systems Biology Approach Based on Comprehensive Gene Information

  2021cites this paper
• Benzo[a]pyrene Immunogenetics and Immune Archetype Reprogramming of Lung.

  2021cites this paper
• Effect of Atypical protein kinase C inhibitor (DNDA) on Cell Proliferation and Migration of Lung Cancer Cells

  2021cites this paper
• SCP Phosphatases and Oncogenesis

  2021cites this paper
• Oncogenic potential of human pluripotent stem cell‐derived lung organoids with HER2 overexpression

  2021cites this paper
• The Tumor Suppressor MTUS1/ATIP1 Modulates Tumor Promotion in Glioma: Association with Epigenetics and DNA Repair

  2021cites this paper
• LUNG CANCER: A DIFFERENTIAL MINI- REVIEW ON SUBTYPES

  2020cites this paper
• Identification of protocatechuic acid as a novel blocker of epithelial‐to‐mesenchymal transition in lung tumor cells

  2020cites this paper
• HAX1 enhances the survival and metastasis of non‐small cell lung cancer through the AKT/mTOR and MDM2/p53 signaling pathway

  2020cites this paper
• Overall survival prediction of non-small cell lung cancer by integrating microarray and clinical data with deep learning

  2020cites this paper
• Effects of Atypical Protein Kinase C Inhibitor (DNDA) on Lung Cancer Proliferation and Migration by PKC-ι/FAK Ubiquitination Through the Cbl-b Pathway

  2020cites this paper
• Immune Modulation in Lung Cancer: Current Concepts and Future Strategies

  2020cites this paper
• Correlation between RASSF1A, P16, DAP Kinase Promoter Hypermethylation and Lung Cancer: Relation with Smoking Status

  2020cites this paper
• Multi-Omics Analysis to Characterize Cigarette Smoke Induced Molecular Alterations in Esophageal Cells

  2020cites this paper
• Tyrosine-phosphorylated SOCS3 negatively regulates cellular transformation mediated by the myeloproliferative neoplasm-associated JAK2 V617F mutant.

  2019cites this paper
• Predicting the Prognosis of Non-Small Cell Lung Cancer by Integrating Microarray and Clinical Data with Deep Learning

  2019cites this paper
• Clinicopathological and prognostic significance of NCALD protein expression in lung adenocarcinoma

  2019cites this paper
• QSAR modeling, pharmacophore-based virtual screening, and ensemble docking insights into predicting potential epigallocatechin gallate (EGCG) analogs against epidermal growth factor receptor

  2019influential citation
• Premalignant lesions of squamous cell carcinoma of the lung: The molecular make-up and factors affecting their progression.

  2019cites this paper
• Cellular Potts Models

  2019cites this paper
• Dietary and Lifestyle Factors in Epigenetic Regulation of Cancer

  2019cites this paper
• Metabolic reprogramming by tobacco-specific nitrosamines (TSNAs) in cancer.

  2019cites this paper
• Synergistic anti-colon cancer effect of glycyrol and butyrate is associated with the enhanced activation of caspase-3 and structural features of glycyrol.

  2019cites this paper
• Knockdown of lncRNA PVT1 Inhibits Glioma Progression by Regulating miR-424 Expression.

  2019cites this paper
• Molecular Insights into Potential Contributions of Natural Polyphenols to Lung Cancer Treatment

  2019cites this paper
• Networking of predicted post-translational modification (PTM) sites in human EGFR

  2019cites this paper
• Causative role of PDLIM2 epigenetic repression in lung cancer and therapeutic resistance

  2019cites this paper
• Extension of tumor fingers: A comparison between an individual-cell based model and a measure theoretic approach

  2019cites this paper
• Enhancement of tumor suppressor RAR-β protein expression by cationic liposomal-ATRA treatment in benzo(a)pyrene-induced lung cancer mice model

  2018cites this paper
• Protein signatures of molecular pathways in non-small cell lung carcinoma (NSCLC): comparison of glycoproteomics and global proteomics

  2017cites this paper
• Molecular Pathology of Lung Tumors

  2017cites this paper
• Differential expression of an ensemble of the key genes involved in cell-cycle regulation in lung cancer

  2017cites this paper
• Long-Term Cigarette Smoke Exposure and Changes in MiRNA Expression and Proteome in Non-Small-Cell Lung Cancer

  2017cites this paper
• Oncogene KRAS activates fatty acid synthase, resulting in specific ERK and lipid signatures associated with lung adenocarcinoma

  2017cites this paper
• Down-regulated GATA-1 up-regulates interferon regulatory factor 3 in lung adenocarcinoma

  2017cites this paper
• Familial risk for lung cancer.

  2017cites this paper
• Role of Proteases in Lung Disease: A Brief Overview

  2017cites this paper
• HES5 promotes cellular proliferation of non-small cell lung cancer through STAT3 signaling.

  2017cites this paper
• Proteases in Human Diseases

  2017cites this paper
• SULF2 Expression Is a Potential Diagnostic and Prognostic Marker in Lung Cancer

  2016cites this paper
• Rap2b promotes proliferation, migration, and invasion of lung cancer cells

  2016cites this paper
• 4-Nitroquinoline-1-oxide effects human lung adenocarcinoma A549 cells by regulating the expression of POLD4.

  2016cites this paper
• Epigenetic profiling of gallbladder cancer and gall stone diseases: Evaluation of role of tumour associated genes.

  2016cites this paper
• Alternative regulation of MYC in lung cancer

  2016cites this paper
• Epigenetic Mechanisms as an Interface Between the Environment and Genome.

  2016cites this paper
• Recent advances in epigenomics in NSCLC: real-time detection and therapeutic implications.

  2016cites this paper
• Nutritional and Lifestyle Impact on Epigenetics and Cancer

  2016cites this paper
• Nuclear Phosphoproteomics Features the Novel Smoking Markers inMouse Lung Tissue Following Subacute Phase Exposure to TobaccoSmoke

  2016cites this paper
• Characteristics of Smoking Patients with Lung Cancer with Emphysematous Bullae

  2016cites this paper
• Xanthohumol inhibits the extracellular signal regulated kinase (ERK) signalling pathway and suppresses cell growth of lung adenocarcinoma cells.

  2016cites this paper
• Familial risk for lung cancer ( Review )

  2016cites this paper
• Strong Down-Regulation of Tumor Suppressor Genes RB1 and CTDSPL is Associated with Aberrant Expression of Cell Cycle Regulation Genes in Non-Small Cell Lung Cancer

  2015cites this paper
• Mdig, a lung cancer-associated gene, regulates cell cycle progression through p27KIP1

  2015cites this paper
• Promoter mutation of tumor suppressor microRNA-7 is associated with poor prognosis of lung cancer.

  2015cites this paper
• Involvement of p29/SYF2/fSAP29/NTC31 in the progression of NSCLC via modulating cell proliferation.

  2015cites this paper
• Molecular diagnosis in lung diseases.

  2015cites this paper
• Upregulated expression of ILF2 in non-small cell lung cancer is associated with tumor cell proliferation and poor prognosis

  2015cites this paper
• Glycosylation alterations in lung and brain cancer.

  2015cites this paper
• Down-regulation of miR-489 contributes into NSCLC cell invasion through targeting SUZ12

  2015cites this paper
• α5-nAChR modulates nicotine-induced cell migration and invasion in A549 lung cancer cells.

  2015cites this paper
• The combination of strong expression of ZNF143 and high MIB-1 labelling index independently predicts shorter disease-specific survival in lung adenocarcinoma

  2014cites this paper
• In silico epigenetic profiling of hypermethylated genes in non-small cell lung cancer

  2014cites this paper
• Identification of nuclear phosphoproteins as novel tobacco markers in mouse lung tissue following short-term exposure to tobacco smoke

  2014cites this paper
• Oxidative Status and Acute Phase Reactants in Patients with Environmental Asbestos Exposure and Mesothelioma

  2014cites this paper
• Epigenetic silencing of microRNA-373 to epithelial-mesenchymal transition in non-small cell lung cancer through IRAK2 and LAMP1 axes.

  2014cites this paper
• The regulation of p53-dependent microRNA expression in response to genotoxic stress

  2014cites this paper
• MOLECULAR EPIDEMIOLOGY OF LUNG CANCER IN THE LIVERPOOL LUNG PROJECT (LLP) COHORT

  2014cites this paper
• Unique volatolomic signatures of TP53 and KRAS in lung cells

  2014cites this paper
• EGFR immunoexpression, RAS immunoexpression and their effects on survival in lung adenocarcinoma cases.

  2014cites this paper
• Pathophysiology of tobacco smoke exposure: recent insights from comparative and redox proteomics.

  2014cites this paper
• New Cancer Stochastic Models Involving Both Hereditary and Nonhereditary Cancer Cases: A New Approach

  2013influential citation
• We review the function of these different proteins , the incidence of mutations in their genes in carcinogenesis and as potential prognostic factors in sporadic and hereditary ovarian cancer

  2013cites this paper
• Correction: VILIP-1 Downregulation in Non-Small Cell Lung Carcinomas: Mechanisms and Prediction of Survival

  2013cites this paper
• Allelotypes of lung adenocarcinomas featuring ALK fusion demonstrate fewer onco- and suppressor gene changes

  2013cites this paper
• Cigarette smoke induces methylation of the tumor suppressor gene NISCH

  2013cites this paper